M. Schiff

842 total citations
10 papers, 656 citations indexed

About

M. Schiff is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, M. Schiff has authored 10 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 4 papers in Genetics and 4 papers in Hematology. Recurrent topics in M. Schiff's work include Rheumatoid Arthritis Research and Therapies (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). M. Schiff is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). M. Schiff collaborates with scholars based in United States, Japan and Canada. M. Schiff's co-authors include Mark C. Genovese, Manuela Le Bars, J. Teng, R. Aranda, Michael E. Luggen, Maxime Dougados, N. Schmidely, J-C Becker, Joseph A. Markenson and B Freundlich and has published in prestigious journals such as Annals of the Rheumatic Diseases and Scandinavian Journal of Rheumatology.

In The Last Decade

M. Schiff

10 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Schiff United States 5 422 201 180 116 86 10 656
Ceara AE Walsh Ireland 10 394 0.9× 158 0.8× 198 1.1× 85 0.7× 112 1.3× 11 717
Emma Vernon United States 5 503 1.2× 256 1.3× 176 1.0× 105 0.9× 58 0.7× 9 738
George Vratsanos United States 9 519 1.2× 186 0.9× 296 1.6× 123 1.1× 42 0.5× 13 738
Lara Valor Spain 13 335 0.8× 134 0.7× 211 1.2× 69 0.6× 28 0.3× 36 560
M. de Longueville Belgium 15 537 1.3× 190 0.9× 376 2.1× 43 0.4× 105 1.2× 30 1.2k
Antonio Iglesias Gamarra Colombia 17 398 0.9× 66 0.3× 144 0.8× 39 0.3× 56 0.7× 94 705
Marina Stanislav Russia 9 430 1.0× 179 0.9× 192 1.1× 126 1.1× 28 0.3× 20 601
L.E. Burgers Netherlands 16 617 1.5× 202 1.0× 126 0.7× 79 0.7× 25 0.3× 23 724
P. Le Goff France 16 430 1.0× 103 0.5× 286 1.6× 53 0.5× 65 0.8× 59 797
Oscar Rillo Argentina 13 340 0.8× 92 0.5× 129 0.7× 63 0.5× 57 0.7× 28 496

Countries citing papers authored by M. Schiff

Since Specialization
Citations

This map shows the geographic impact of M. Schiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schiff more than expected).

Fields of papers citing papers by M. Schiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schiff. The network helps show where M. Schiff may publish in the future.

Co-authorship network of co-authors of M. Schiff

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schiff. A scholar is included among the top collaborators of M. Schiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schiff. M. Schiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Strand, Vibeke, et al.. (2017). THU0210 Changes in hemoglobin levels upon treatment with ABT-494, a selective JAK-1 inhibitor, and relation to baseline levels of C-reactive protein. Annals of the Rheumatic Diseases. 76. 283–283. 2 indexed citations
2.
Tanaka, Yoshiya, R. Fleischmann, M. Schiff, et al.. (2016). THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM). Annals of the Rheumatic Diseases. 75. 262–263. 3 indexed citations
3.
Weinblatt, Michael E., Patrick Taylor, Yoshiya Tanaka, et al.. (2016). THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies. Annals of the Rheumatic Diseases. 75. 255–256. 3 indexed citations
4.
5.
Genovese, Mark C., M. Schiff, Michael E. Luggen, et al.. (2007). Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Annals of the Rheumatic Diseases. 67(4). 547–554. 204 indexed citations
6.
Schiff, M., et al.. (2006). Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 65(7). 889–894. 308 indexed citations
7.
Schiff, M., et al.. (2001). FRI0077 Durability and rapidity of response for rheumatoid arthritis patients receiving therapy with anakinra (il-1ra). Annals of the Rheumatic Diseases. 60. A477–A477. 5 indexed citations
8.
Fleischmann, Roy, Stephan Baumgartner, Larry W. Moreland, et al.. (2001). FRI0081 Improvement of disability in ra patients with early vs established disease after treatment with enbrel® (etanercept). Annals of the Rheumatic Diseases. 60. A478–A478. 4 indexed citations
9.
Schiff, M.. (2000). Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Annals of the Rheumatic Diseases. 59. i103–i108. 111 indexed citations
10.
Schiff, M.. (1999). Leflunomide versus methotrexate: A comparison of the European and American experience. Scandinavian Journal of Rheumatology. 28(sup112). 31–35. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ceara AE Walsh Breakdown of academic impact, for papers by Emma Vernon Breakdown of academic impact, for papers by George Vratsanos Breakdown of academic impact, for papers by Lara Valor Breakdown of academic impact, for papers by M. de Longueville Breakdown of academic impact, for papers by Antonio Iglesias Gamarra Breakdown of academic impact, for papers by Marina Stanislav Breakdown of academic impact, for papers by L.E. Burgers Breakdown of academic impact, for papers by P. Le Goff Breakdown of academic impact, for papers by Oscar Rillo
Rankless by CCL
2026